| Shelly Rishty, MD | |
|
125 Paterson St Ste 6100, New Brunswick, NJ 08901-1962 | |
| (732) 235-7733 | |
| Not Available |
| Full Name | Shelly Rishty |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 12 Years |
| Location | 125 Paterson St Ste 6100, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053678672 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Robert Wood Johnson University Hospital | New brunswick, NJ | Hospital |
| Robert Wood Johnson University Hospital At Rahway | Rahway, NJ | Hospital |
| Trinitas Regional Medical Center | Elizabeth, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rutgers Health-rwj Scleroderma Program | 5193764991 | 291 |
| Trinitas Physicians Practice Llc | 6709002850 | 28 |
News Archive
Paladin Labs Inc. and Labopharm Inc. announced today that they have entered into a definitive agreement pursuant to which Paladin will acquire all of the issued and outstanding common shares of Labopharm at a price of $0.2857 per share in cash, which represents a premium of 57.4% over the volume-weighted average price of Labopharm's shares of $0.1815 for the 30 trading days prior to this announcement.
The National Association of Boards of Pharmacy(R) (NABP(R)) welcomes Office of National Drug Control Policy drug policy expert Kevin Sebat to speak at its 2009 Symposium. On December 3, 2009, Sebat will discuss the current federal laws regarding marijuana as well as the recent policy shift regarding prosecution of medical marijuana cases in states that have legalized the practice.
Researchers in Italy say losing weight can bring down a person's hypertension; they say even a moderate weight loss can lower high blood pressure to within the normal range.
World renowned and esteemed Australian virologist Professor Frank Fenner will present the inaugural Rod Andrew Oration this week at Monash University. His topic "Big lessons from smallpox: bioterrorism and emerging infections" is timely and sure to be thought-provoking.
BioTrove announced a collaboration with the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research to investigate the utility of the company's Standardized NanoArray PCR (SNAP) gene expression profiling system for the rapid and specific detection of pathogens in the nation's blood supply.
› Verified 8 days ago
| Entity Name | Rutgers Health-rwj Neurology Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366487183 PECOS PAC ID: 2860485141 Enrollment ID: O20040405000110 |
News Archive
Paladin Labs Inc. and Labopharm Inc. announced today that they have entered into a definitive agreement pursuant to which Paladin will acquire all of the issued and outstanding common shares of Labopharm at a price of $0.2857 per share in cash, which represents a premium of 57.4% over the volume-weighted average price of Labopharm's shares of $0.1815 for the 30 trading days prior to this announcement.
The National Association of Boards of Pharmacy(R) (NABP(R)) welcomes Office of National Drug Control Policy drug policy expert Kevin Sebat to speak at its 2009 Symposium. On December 3, 2009, Sebat will discuss the current federal laws regarding marijuana as well as the recent policy shift regarding prosecution of medical marijuana cases in states that have legalized the practice.
Researchers in Italy say losing weight can bring down a person's hypertension; they say even a moderate weight loss can lower high blood pressure to within the normal range.
World renowned and esteemed Australian virologist Professor Frank Fenner will present the inaugural Rod Andrew Oration this week at Monash University. His topic "Big lessons from smallpox: bioterrorism and emerging infections" is timely and sure to be thought-provoking.
BioTrove announced a collaboration with the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research to investigate the utility of the company's Standardized NanoArray PCR (SNAP) gene expression profiling system for the rapid and specific detection of pathogens in the nation's blood supply.
› Verified 8 days ago
| Entity Name | Rutgers Health-rwj Scleroderma Program |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679655781 PECOS PAC ID: 5193764991 Enrollment ID: O20050502000326 |
News Archive
Paladin Labs Inc. and Labopharm Inc. announced today that they have entered into a definitive agreement pursuant to which Paladin will acquire all of the issued and outstanding common shares of Labopharm at a price of $0.2857 per share in cash, which represents a premium of 57.4% over the volume-weighted average price of Labopharm's shares of $0.1815 for the 30 trading days prior to this announcement.
The National Association of Boards of Pharmacy(R) (NABP(R)) welcomes Office of National Drug Control Policy drug policy expert Kevin Sebat to speak at its 2009 Symposium. On December 3, 2009, Sebat will discuss the current federal laws regarding marijuana as well as the recent policy shift regarding prosecution of medical marijuana cases in states that have legalized the practice.
Researchers in Italy say losing weight can bring down a person's hypertension; they say even a moderate weight loss can lower high blood pressure to within the normal range.
World renowned and esteemed Australian virologist Professor Frank Fenner will present the inaugural Rod Andrew Oration this week at Monash University. His topic "Big lessons from smallpox: bioterrorism and emerging infections" is timely and sure to be thought-provoking.
BioTrove announced a collaboration with the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research to investigate the utility of the company's Standardized NanoArray PCR (SNAP) gene expression profiling system for the rapid and specific detection of pathogens in the nation's blood supply.
› Verified 8 days ago
| Entity Name | Trinitas Physicians Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205189941 PECOS PAC ID: 6709002850 Enrollment ID: O20140725000027 |
News Archive
Paladin Labs Inc. and Labopharm Inc. announced today that they have entered into a definitive agreement pursuant to which Paladin will acquire all of the issued and outstanding common shares of Labopharm at a price of $0.2857 per share in cash, which represents a premium of 57.4% over the volume-weighted average price of Labopharm's shares of $0.1815 for the 30 trading days prior to this announcement.
The National Association of Boards of Pharmacy(R) (NABP(R)) welcomes Office of National Drug Control Policy drug policy expert Kevin Sebat to speak at its 2009 Symposium. On December 3, 2009, Sebat will discuss the current federal laws regarding marijuana as well as the recent policy shift regarding prosecution of medical marijuana cases in states that have legalized the practice.
Researchers in Italy say losing weight can bring down a person's hypertension; they say even a moderate weight loss can lower high blood pressure to within the normal range.
World renowned and esteemed Australian virologist Professor Frank Fenner will present the inaugural Rod Andrew Oration this week at Monash University. His topic "Big lessons from smallpox: bioterrorism and emerging infections" is timely and sure to be thought-provoking.
BioTrove announced a collaboration with the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research to investigate the utility of the company's Standardized NanoArray PCR (SNAP) gene expression profiling system for the rapid and specific detection of pathogens in the nation's blood supply.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shelly Rishty, MD Po Box 829642, Philadelphia, PA 19182-9642 Ph: (866) 470-6626 | Shelly Rishty, MD 125 Paterson St Ste 6100, New Brunswick, NJ 08901-1962 Ph: (732) 235-7733 |
News Archive
Paladin Labs Inc. and Labopharm Inc. announced today that they have entered into a definitive agreement pursuant to which Paladin will acquire all of the issued and outstanding common shares of Labopharm at a price of $0.2857 per share in cash, which represents a premium of 57.4% over the volume-weighted average price of Labopharm's shares of $0.1815 for the 30 trading days prior to this announcement.
The National Association of Boards of Pharmacy(R) (NABP(R)) welcomes Office of National Drug Control Policy drug policy expert Kevin Sebat to speak at its 2009 Symposium. On December 3, 2009, Sebat will discuss the current federal laws regarding marijuana as well as the recent policy shift regarding prosecution of medical marijuana cases in states that have legalized the practice.
Researchers in Italy say losing weight can bring down a person's hypertension; they say even a moderate weight loss can lower high blood pressure to within the normal range.
World renowned and esteemed Australian virologist Professor Frank Fenner will present the inaugural Rod Andrew Oration this week at Monash University. His topic "Big lessons from smallpox: bioterrorism and emerging infections" is timely and sure to be thought-provoking.
BioTrove announced a collaboration with the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research to investigate the utility of the company's Standardized NanoArray PCR (SNAP) gene expression profiling system for the rapid and specific detection of pathogens in the nation's blood supply.
› Verified 8 days ago
Janti Chaaban, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 254 Easton Ave, Pediatric Neurology, New Brunswick, NJ 08901 Phone: 732-745-8600 | |
Carlos Lastra, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-339-7870 Fax: 732-745-1632 | |
Dr. Emad Nourollah-zadeh, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Robert Wood Johnson University Hospital, 125 Paterson Street,, New Brunswick, NJ 08901 Phone: 732-235-7041 | |
Shan Chen, MD, PHD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St, Suite 6100, New Brunswick, NJ 08901 Phone: 732-235-7733 Fax: 732-235-7041 | |
Dr. Susan F Janes, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 11 Bishop Pl, New Brunswick, NJ 08901 Phone: 732-932-7402 Fax: 732-932-1223 | |
Lawrence I Golbe, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 125 Paterson St, Suite 6100, New Brunswick, NJ 08901 Phone: 732-235-7733 Fax: 732-235-7041 |